Delivery Order SPE2DB20D1004-SPE2DB21FF5G8
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order worth $1,311.38 for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" from the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the...
- This federal contract award is for a Prime Vendor Pharmaceutical Branch in Philadelphia, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order is a firm fixed-price contract valued at $2,337.72, with a performance period through April 16, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $50,327.73 for pharmaceutical and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) for the Prime Vendor Pharmaceutical Branch in Philadelphia. The contract is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $3,311.20 for a Prime Vendor Pharmaceutical Branch in Philadelphia. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 11, 2021. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for a Prime Vendor Pharmaceutical Branch-Philadelphia contract with the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $3,934.14, is a Firm Fixed Price Delivery Order with an ultimate completion date of December 16, 2020. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,089.55 delivery order was issued by the Defense Logistics Agency (DLA) for the "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" requirement. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 26, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $2,099.76 Firm Fixed Price delivery order is for a Prime Vendor Pharmaceutical Branch-Philadelphia, with an ultimate completion date of December 1, 2020. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,103.80 for providing a prime vendor pharmaceutical distribution service to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of November 10, 2020 and is a firm fixed-price, indefinite delivery vehicle. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $2,243.82 for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA". The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DB20D3103|SPE2DB21FN4F4) with a Ceiling Value of $1,405.50 from the Defense Logistics Agency (DLA). The contract is for Prime Vendor Pharmaceutical Branch-Philadelphia, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FF5G8Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order with a Firm Fixed Price valued at $4,358.74. The contract is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with an ultimate completion date of May 4, 2021. The contracting agency is the Defense Logistics Agency (DLA), a defense agency. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 5/3/21 |